Ir para o conteúdo principal

United States News Todas as matérias

Todas as matérias desta seção, das mais recentes às mais antigas — página 238 de 371.

Grafa

Scienture revenue rallies 216% in 2025 on Arbli launch and record margin expansion

Scienture (NASDAQ:SCNX), a specialty pharmaceutical company focused on developing and commercializing innovative therapies for underserved patient populations, today reported its financial results for the full year ended December 31, 2025.

Leia mais: Scienture revenue rallies 216% in 2025 on Arbli launch and record margin expansion
Grafa

Reviva Pharmaceuticals narrows path to Brilaroxazine FDA submission with 2026 Phase 3 launch

Reviva Pharmaceuticals Holdings (NASDAQ:RVPH), a clinical-stage pharmaceutical company developing next-generation therapies for central nervous system (CNS) disorders, today announced its financial results and corporate updates for the full year ended December 31, 2025.

Leia mais: Reviva Pharmaceuticals narrows path to Brilaroxazine FDA submission with 2026 Phase 3 launch
Grafa

Unicycive Therapeutics reports FY 2025 financial results and provides update on oxylanthanum carbonate NDA

Unicycive Therapeutics (NASDAQ:UNCY), a clinical-stage biopharmaceutical company focused on kidney disease therapies, reported its full-year 2025 financial results and provided a business update on March 30, 2026.

Leia mais: Unicycive Therapeutics reports FY 2025 financial results and provides update on oxylanthanum carbonate NDA
Grafa
Oil and Gas

Oil holds near $115 as Trump balances peace optimism with threats to Iran’s Kharg Island

Oil markets remained on edge Monday, with Brent crude holding near $115 a barrel, as President Donald Trump indicated a potential diplomatic breakthrough in the Middle East while simultaneously threatening military strikes against Iran’s critical energy infrastructure.

Leia mais: Oil holds near $115 as Trump balances peace optimism with threats to Iran’s Kharg Island
Grafa

Eikon Therapeutics reports 2025 financial results and clinical pipeline progress

Eikon Therapeutics (NASDAQ:EIKN), a clinical-stage biotechnology company focused on developing novel medicines through advanced imaging and machine learning platforms, reported corporate and clinical updates on March 30, 2026, alongside its full-year 2025 financial results.

Leia mais: Eikon Therapeutics reports 2025 financial results and clinical pipeline progress
Grafa
Energy

Soluna Holdings reports revenue growth in Q4 2025 driven by Dorothy 2 expansion

Soluna Holdings (NASDAQ:SLNH), a specialized developer of green data centers for intensive computing applications such as Bitcoin mining and artificial intelligence, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

Leia mais: Soluna Holdings reports revenue growth in Q4 2025 driven by Dorothy 2 expansion
Grafa
Energy

Terrestrial Energy strengthens US footprint with site selection and $292M capital raise

Terrestrial Energy (NASDAQ:IMSR), a developer of Generation IV advanced nuclear technology, today announced its financial results and program milestones for the fourth quarter and full year ended December 31, 2025.

Leia mais: Terrestrial Energy strengthens US footprint with site selection and $292M capital raise